Bettie M. Steinberg, Ph.D.
Dr. Steinberg did her undergraduate work at the University of California, Riverside. She received her Ph.D. in Microbiology from the State University of New York, Stony Brook in 1976, working on bacterial viruses. She then did a postdoctoral fellowship at SUNY Stony Brook, studying mammalian tumor viruses. After two years at Columbia University as a Senior Research Associate, she joined the Department of Otolaryngology at Long Island Jewish Medical where she began her studies of human papillomaviruses and recurrent respiratory papillomatosis. Those studies have been supported continuously by grants from the National Institutes of Health (NIH) since 1983. She is the author or co-author of 96 peer-reviewed publications and 27 book chapters, most dealing with papillomaviruses. Her research has been recognized by receipt of a number of awards, including the Robert K. Match Distinguished Scientist Award, the Long Island Achiever in Science from the Long Island Center for Business and Professional Women, the Elliot Osserman Award from the Israel Cancer Research Fund, the Karl Storz Award from the American Society of Pediatric Otolaryngology, the Lorinda de Roulet Award for Excellence in Research, and the Israel Cancer Research Fund Award for Women of Excellence.
Dr. Steinberg holds multiple positions within Northwell Health: Chief Scientific Officer for The Feinstein Institute for Medical Research, Dean of the Elmezzi Graduate School of Molecular Medicine, and Chair of the Department of Molecular Medicine, Hofstra Northwell School of Medicine at Hofstra University. She has academic appointments as Professor in the Elmezzi Graduate School, is Professor of Otorhinolaryngology – Head & Neck Surgery and Professor of Microbiology & Immunology at the Albert Einstein College of Medicine, where she is a member of the Cancer Center and is Adjunct Associate Professor of Molecular Genetics and Microbiology and Adjunct Associate Professor of Oral Biology and Pathology at SUNY Stony Brook. She has previously served as a member of the Advisory Council for the National Institute on Deafness and Other Communication Disorders at NIH, a member of the Communication Disorders Review Committee Study Section at NIH, a member of the Israel Cancer Research Fund Scientific Review Panel, a member of the Institutional Review Group for the American Cancer Society and a member of the Vaccine Advisory Board for Merck & Company. She is currently Chair of the Institutional Review Group for the American Cancer Society.